Iodide

Iodide

SCHEMBL4110593

CN(C)CCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.60
▸ HRH1 P35367 2/20 0.60
▸ HIF1A Q16665 1/20 0.54
▸ SIGMAR1 Q99720 1/20 0.46
▸ CHRNA7 P36544 8/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ LSS P48449 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8861752 0.96 HTR2A (0.60) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Bromide SCHEMBL190865 0.96 HTR2A (0.60) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Bromide SCHEMBL246032 0.94 HTR2A (0.58) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Bromide SCHEMBL28158895 0.92 HTR2A (0.56) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Bromide SCHEMBL8909571 0.90 HTR2A (0.53) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Hydrochloric Acid SCHEMBL9549516 0.90 HTR2A (0.53) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Bromide SCHEMBL8782143 0.89 HTR2A (0.52) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Iodide SCHEMBL9549744 0.88 HIF1A (0.58) HTR2AHRH1HIF1AALDH1A1CYP1A2
Bromide SCHEMBL9147651 0.87 HTR2A (0.50) HTR2AHRH1HIF1ASIGMAR1CHRNA7
Acetic Acid SCHEMBL9549706 0.86 HTR2A (0.50) HTR2AHRH1HIF1ASIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612219-B2 11—[ (Z) -3- (dimethylamino) propylidene]—6, 11-dihydro-dibenz [B,E] oxepin-2-YI ]—acetic acid URQUIMA S.A. (ES) 2009-11-03 — — US disclosed
WO-2009081417-A2 PROCESS FOR PREPARATION OF OLOPAT ADINE HYDROCHLORIDE INDOCO REMEDIES LIMITED (IN) 2009-07-02 — — WO disclosed
US-20090005579-A1 11 - [ (Z) -3- (Dimethylamino) Propylidene] - 6, 11-Dihydro-Dibenz [B,E] Oxepin-2-Yl] - Acetic Acid URQUIMA S.A. (ES) 2009-01-01 — — US disclosed
EP-1908758-A1 Process for the preparation of (Z)-[11-(3-dimethylamino-propyliden)-6,11-dihydro-dibenzo[b,e]oxepin-2-yl]-acetic acid hydrochloride Urquima S.A. (ES) 2008-04-09 — — EP disclosed
EP-1778665-A1 PROCESS FOR THE PREPARATION OF 11-[(Z)-3-(DIMETHYLAMINO)PROPYLIDENE]-6,11-DIHYDRO-DIBENZ[B,E]OXEPIN-2-YL]ACETIC ACID Urquima S.A. (ES) 2007-05-02 — — EP disclosed
WO-2006010459-A1 PROCESS FOR THE PREPARATION OF 11-[(Z)-3-(DIMETHYLAMINO)PROPYLIDENE]-6,11-DIHYDRO-DIBENZ[B,E]OXEPIN-2-YL]-ACETIC ACID URQUIMA S.A. (ES) 2006-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005579-A1 11 - [ (Z) -3- (Dimethylamino) Propylidene] - 6, 11-Dihydro-Dibenz [B,E] Oxepin-2-Yl] - Acetic Acid OPRD1, OPRK1, MAOB HTR2A 156/4885HRH1 50/4885HIF1A 838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback